Evidence map›Paper›PMID 33906310›Full record

SynthesisAsian Pacific journal of cancer prevention : APJCP2021

BAX -248 G>A and BCL2 -938 C>A Variant Lowers the Survival in Patients with Nasopharyngeal Carcinoma and Could be Associated with Tissue-Specific Malignancies: A Multi-Method Approach.

Koustav Chatterjee, Saikat De, Sankar Deb Roy, Sushil Kumar Sahu, Arindom Chakraborty, Sandeep Ghatak, Nilanjana Das, Sudipa Mal, Nabanita Roy Chattopadhyay, Piyanki Das and 11 more

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in Asian Pacific journal of cancer prevention : APJCP, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. In Silico and Wet Analysis ofCurrent issues in molecular biology · 2025
    Article
  5. Positive correlation betweenInternational journal of reproductive biomedicine · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 9 institutions in 2 countries.

Koustav ChatterjeeDepartment of Biotechnology, Visva-Bharati, Santiniketan, Birbhum, West Bengal, India.ORCID 0000-0003-4200-0538
Saikat DeDepartment of Biotechnology, Visva-Bharati, Santiniketan, Birbhum, West Bengal, India.
Sankar Deb RoyDepartment of Radiation Oncology, Eden Medical Centre, Dimapur, Nagaland, India.
Sushil Kumar SahuDepartment of Pharmacology and Molecular Sciences, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States.
Arindom ChakrabortyDepartment of Statistics, Visva-Bharati, Santiniketan, West Bengal, India.
Sandeep GhatakDivision of Animal and Fishery Science, ICAR Research Complex for North East Hill Region,Umiam, Meghalaya, India.
Nilanjana DasDepartment of Biotechnology, Visva-Bharati, Santiniketan, Birbhum, West Bengal, India.
Sudipa MalDepartment of Biotechnology, Visva-Bharati, Santiniketan, Birbhum, West Bengal, India.
Nabanita Roy ChattopadhyayDepartment of Biotechnology, Visva-Bharati, Santiniketan, Birbhum, West Bengal, India.
Piyanki DasDepartment of Biotechnology, Visva-Bharati, Santiniketan, Birbhum, West Bengal, India.
R Rajendra ReddyClinical Proteomics, Institute of Life Sciences, Bhubaneswar, India.
Syamantak MukherjeeDepartment of Biotechnology, Visva-Bharati, Santiniketan, Birbhum, West Bengal, India.
Ashok Kumar DasDepartment of ENT, Dr B. Borooah Cancer Institute, Guwahati, Assam, India.
Zoreng PuiiState Referral Hospital, Falkawn, Mizoram, India.
Eric ZomawiaState Referral Hospital, Falkawn, Mizoram, India.
Yengkhom Indibor SinghRegional Institute of Medical Sciences, Department of Radiotherapy, Imphal, Manipur, India.
Sam TseringTertiary cancer center,TomoRiba Institute of Health And Medical Sciences, Arunachal Pradesh, India.
Komri RibaTertiary cancer center,TomoRiba Institute of Health And Medical Sciences, Arunachal Pradesh, India.
Shanmugam RajasubramaniamDivision of Genetic Disorders ICMR-National Institute of Research in Tribal Health, NIRTH Complex, Jabalpur, Madhya Pradesh, India.
Amol Ratnakar SuryawanshiClinical Proteomics, Institute of Life Sciences, Bhubaneswar, India.
Tathagata ChoudhuriDepartment of Biotechnology, Visva-Bharati, Santiniketan, Birbhum, West Bengal, India.ORCID 0000-0003-4022-0318
Visva-Bharati University · INInstitute of Life Sciences · INNational Institute of Technology Arunachal Pradesh · INBhubaneswar Borooah Cancer Institute · INChristian Institute of Health Sciences and Research Hospital · INICAR Research Complex for NEH Region · INJohns Hopkins University · USNational Institute for Research in Tribal Health · INRegional Institute of Medical Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe association of BAX -248 G>A and BCL2 -938 C>A with different cancers created conflicts.  We studied the correlation and the effect of these polymorphisms in patients with Nasopharyngeal Carcinoma (NPC).  Methods: PCR-RFLP and Sanger sequencing were used to detect polymorphisms. Statistical analysis including forest plot and Kaplan-Meier Log-rank test was conducted to investigate the association and effect of these SNPs on the NPC patients' survival. The computational study was performed to investigate the possible regulatory role between these polymorphisms and the poor survival of NPC patients. Meta-analysis was executed to check the tissue-specific association of these polymorphisms in the context of global cancer prognosis.

resultsWe observed an increased and significant association of BAX -248 G>A [GA:OR=5.29, 95%CI=1.67,16.67, P=0.004; GA+AA:OR=5.71, 95%CI=1.82,17.90, P =0.002; A:OR=5.33, 95%CI=1.76,16.13, P=0.003], and BCL2 -938 C>A [CA:OR=2.26, 95%CI=1.03,4.96, P=0.04; AA:OR=3.56, 95%CI=0.97,13.05, P=0.05; CA+AA:OR=3.10, 95%CI=1.51,6.35, P=0.002; A:OR=2.90, 95% CI=1.59,5.29, P=0.0005] with the risk of NPC. Also, these SNPs were strongly correlated with poor survival in NPC patients (lower estimated survival mean, lower estimated proportion surviving at 5 years with p <0.05). The computational study showed that these SNPs altered the binding affinity of transcription factors HIF1, SP1, PAX3, PAX9 and CREB towards promoter (Lower p indicates strong affinity). The meta-analysis revealed the tissue-specific association of these polymorphisms. BAX -248 G>A showed a significant correlation with carcinomas [A vs G:OR=1.60, 95%CI=1.09,2.34, P=0.01; AA vs GG:OR=2.61, 95%CI=1.68,4.06, p <0.001; AA+GA vs GG:OR=1.53,95%CI=1.04,2.25, P=0.02); AA vs GG+GA:OR=2.53, 95%CI=1.65,3.87, p <0.001], and BCL2 -938 C>A with other malignancies [A vs C:OR=1.45, 95%CI=1.26,1.66, p <0.001; AA vs CC:OR=2.07, 95%CI: 1.15,3.72, P=0.01; AA+CA vs CC:OR=1.42, 95%CI=1.18,1.72, p <0.001; AA vs CC+CA:OR=1.89, 95%CI=1.02,3.50, P=0.04].

conclusionsBAX -248 G>A and BCL2 -938 C>A was associated with poor survival in NPC patients. It may increase cancer susceptibility through transcriptional regulation. Moreover, these SNPs' effects could be tissue-specific.<br />.

Indexed as

bcl-2-Associated X ProteinCase-Control StudiesFemaleGenetic Predisposition to DiseaseHumansIndiaKaplan-Meier EstimateMaleNasopharyngeal CarcinomaNasopharyngeal NeoplasmsPolymorphism, GeneticProto-Oncogene Proteins c-bcl-2Survival Ratebcl-2-Associated X ProteinBCL2 protein, humanProto-Oncogene Proteins c-bcl-2Computational studyMeta-analysisNasopharyngeal carcinomaSingle nucleotide polymorphism

Identifiers

PMID33906310
PMCPMC8325122
OpenAlexW3159298163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.